Innovate UK is offering up to £25.4 million to support the clinical validation and evaluation of early cancer diagnostic technologies and devices. This funding is for researchers and startups developing innovative solutions for accelerated cancer diagnosis. The key requirement is to demonstrate the clinical validity and evaluability of the proposed technologies.